1,475
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Oral Bifidobacterium longum expressing alpha-melanocyte-stimulating hormone to fight experimental colitis

, , , , &
Pages 2058-2064 | Received 20 Jul 2015, Accepted 31 Aug 2015, Published online: 16 Dec 2015

References

  • Ayoubi TA, Creemers JW, Roebroek AJ, et al. (1994). Expression of the dibasic proprotein processing enzyme furin is directed by multiple promoters. J Biol Chem 269:9298–303.
  • Brzoska T, Böhm M, Lügering A, et al. (2010). Terminal signal: anti-inflammatory effects of α-melanocyte stimulating hormone related peptides beyond the pharmacophore. Adv Exp Med Biol 681:107–16.
  • Brzoska T, Luger TA, Maaser C, et al. (2008). αMelanocyte stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Rev 29:581–602.
  • Chin J, Mahmud KAF, Kim S, et al. (2012). Insight of current technologies for oral delivery of proteins and peptides. Drug Discov Today Technol 9:e171–4.
  • Choonara BF, Choonara YE, Kumar P, et al. (2014). A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnol Adv 32:1269–82.
  • Fichna J, Dicay M, Lewellyn K, et al. (2012). Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors. Inflamm Bowel Dis 18:1137–45.
  • Fu GF, Li X, Hou YY, et al. (2005). Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer. Cancer Gene Ther 12:133–40.
  • Gambero A, Maróstica M, Abdalla Saad MJ, Pedrazzoli J, Jr. (2007). Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflamm Bowel Dis 13:1357–64.
  • Gendron FP, Mongrain S, Laprise P, et al. (2006). The CDX2 transcription factor regulates furin expression during intestinal epithelial cell differentiation. Am J Physiol Gastrointest Liver Physiol 290:G310–8.
  • Henrich S, Cameron A, Bourenkov GP, et al. (2003). The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Mol Biol 10:520–6.
  • Lipton JM. (1990). Modulation of host defense by the neuropeptide alpha-MSH. Yale J Biol Med 63:173–82
  • Luger TA, Brzoska T. (2007). αMSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis 66:52–5.
  • Matteuzzi D, Brigidi P, Rossi M, Di D. (1990). Characterization and molecular cloning of Bifidobacterium longum cryptic plasmid pMB1. Lett Appl Microbiol 11:220–3.
  • Muheem A, Shakeel F, Jahangir MA, et al. (2014). A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm J. [Epub ahead of print]. doi:10.1016/j.jsps.2014.06.004.
  • Neuman MG. (2007). Immune dysfunction in inflammatory bowel disease. Transl Res 149:173–86.
  • Oatley JT, Rarick MD, Ji GE, Linz JE. (2000). Binding of aflatoxin B1 to bifidobacteria in vitro. J Food Prot 63:1133–6.
  • Park K, Kwon IC, Park K. (2011). Oral protein delivery: current status and future prospect. React Funct Polym 71:280–7.
  • Park MS, Kwon B, Shim JJ, et al. (2008). Heterologous expression of cholesterol oxidase in Bifidobacterium longum under the control of 16S rRNA gene promoter of bifidobacteria. Biotechnol Lett 30:165–72.
  • Park MS, Seo JM, Kim JY, Ji GE. (2005). Heterologous gene expression and secretion in Bifidobacterium longum. Lait 85:1–8.
  • Rajora N, Boccoli G, Catania A, Lipton JM. (1997). alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18:381–5.
  • Reyes Escogido ML, De León Rodríguez A, Barba de la Rosa AP. (2007). A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum. Biotechnol Lett 29:1249–53.
  • Rossi M, Brigidi P, Matteuzzi D. (1997). An efficient transformation system for Bifidobacterium spp. Lett Appl Microbiol 24:33–6.
  • Rubinstein A. (2005). Colonic drug delivery. Drug Discov Today Technol 2:33–7.
  • Sambrook J, Russell DW. (2001). Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press.
  • Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. (2008). Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14:4280–8.
  • Singh M, Mukhopadhyay K. (2014). Alpha-melanocyte stimulating hormone: an emerging anti-inflammatory antimicrobial peptide. Biomed Res Int 2014:874610
  • Tian P, Xu B, An G, et al. (2014). A new therapies for intestinal flora imbalance used ampicillin resistant probiotics. J Microbiol Biotechnol 24:1300–12.
  • Trifunović J, Miller L, Debeljak Ž, Horvat V. (2015). Pathologic patterns of interleukin 10 expression-a review. Biochem Med 25:36–48.
  • Van Kemseke C, Belaiche J, Louis E. (2000). Frequently relapsing Crohn’s disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis 15:206–10.
  • Xu G, Bell SL, McCool D, et al. (2000). The cationic C-terminus of rat Muc2 facilitates dimer formation post translationally and is subsequently removed by furin. Eur J Biochem 267:2998–3004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.